Hamoon Eshraghi
Ophthalmology · Fountain Hill, PANPI 1114410222
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,884 of the $3,935 with a category attached, or 73.3%. 24 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 35.0% of the total.
Across 95 payments — averaging $41.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
- Sun Pharmaceutical Industries Inc.$332
- Oyster Point Pharma, Inc.$283
- Johnson & Johnson$247
- Alcon$240
- Tarsus Pharmaceuticals, Inc.$192
- plus $1K from 18 others
What the payments were for
- Travel & lodging$95124%
- Food & beverage$2,88473%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 14 | $1,377 |
| Sun Pharmaceutical Industries Inc. | 12 | $332 |
| Oyster Point Pharma, Inc. | 12 | $283 |
| Johnson & Johnson | 2 | $247 |
| Alcon | 10 | $240 |
| Tarsus Pharmaceuticals, Inc. | 6 | $192 |
| AbbVie(2 entities) | 4 | $187 |
| Apellis Pharmaceuticals, Inc. | 2 | $137 |
| Bausch & Lomb Americas Inc. | 7 | $122 |
| Sunovion Pharmaceuticals Inc. | 1 | $121 |
| Amgen | 3 | $114 |
| Intuitive Surgical | 1 | $100 |
| Astellas Pharma US Inc | 3 | $91 |
| Harrow Eye, LLC | 4 | $89 |
| Thea Pharma Inc. | 3 | $59 |
| Dompe US, Inc. | 2 | $49 |
| Mallinckrodt Hospital Products Inc. | 2 | $42 |
| Rxsight Inc | 1 | $32 |
| Biotissue Holdings Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| Biogen | 1 | $21 |
| Glaukos Corporation | 1 | $20 |
| Sight Sciences, Inc. | 1 | $18 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPHTHALMIC INSTRUMENTS$940
- TRULIGN TORIC$940
- ENVISTA$940
- CRYSTALENS$940
- XARELTO$247
- LONHALA MAGNAIR$121
- CEQUA$106
- Da Vinci Surgical System$100
How this compares
$3,935 in reported general payments places this provider in the 75th percentile of 920 ophthalmology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 58 | $1,005 |
| Prednisolone Acetate | 19 | $648 |
| Azelastine Hcl | 14 | $313 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 19 | $278 |
| Ofloxacin | 19 | $196 |
| Brimonidine Tartrate | 22 | $132 |
| Timolol Maleate | 11 | $127 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Fountain Hill
- Julia HallerPhiladelphia$1.5M
- Francis MahPittsburgh$1.1M
- Brandon AyresBala Cynwyd$929K
- David AlmeidaErie$734K
- Carl RegilloPlymouth Meeting$721K
- Robert NoeckerPittsburgh$632K
- Beeran MeghparaPhiladelphia$496K
- Michael KlufasPlymouth Meeting$393K
- Jonathan MyersPhiladelphia$359K
- Mark BlecherPhiladelphia$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.